<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="63801">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01929837</url>
  </required_header>
  <id_info>
    <org_study_id>T69/2013</org_study_id>
    <nct_id>NCT01929837</nct_id>
  </id_info>
  <brief_title>Tinnitus rTMS 2013</brief_title>
  <official_title>Treatment of Tinnitus With Transcranial Magnetic Stimulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Turku University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Satakunta Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Turku University Hospital</source>
  <oversight_info>
    <authority>Finland: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Tinnitus is the perception of sound in the absence of corresponding external sound. Tinnitus
      affects approximately 10-15 % of the population. The prevalence increases with age and it is
      estimated that more than 20 % of the older people have tinnitus. Approximately 10-15 % of
      tinnitus patients have clinically relevant, disabling tinnitus causing for example anxiety,
      depression and sleep disturbances. The treatment of chronic tinnitus is difficult and most
      therapies focus on alleviating the condition rather than treating the cause. Pathophysiology
      of tinnitus still remains incompletely understood. Functional brain imaging data in tinnitus
      patients and animal models suggest that tinnitus is associated with increased neuronal
      activity, increased synchronicity, and functional reorganization within the auditory cortex
      either uni- or bilaterally, but there are also functional alterations in brain areas outside
      the auditory system. Transcranial magnetic stimulation (TMS) is a neuromodulation technique
      based on the principle of electromagnetic induction of an electric field in the brain by
      means of magnetic pulses given to the scalp. TMS is a non-invasive, painless, and safe
      method for modulation of cortical activity. TMS pulses given at low frequencies (â‰¤ 1 Hz)
      have been shown to decrease cortical excitability both in experimental settings and humans,
      which forms the basis for using low frequency rTMS to treat chronic tinnitus patients, in
      whom hyperactivity of the auditory cortex has been observed in functional brain imaging
      studies
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2013</start_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>The change of loudness and pitch of the tinnitus is psychophysically measured, VAS questionnaires, Tinnitus Handicap Inventory, Tinnitus diary</measure>
    <time_frame>Change from baseline and 2-3 days after treatment period</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Tinnitus</condition>
  <arm_group>
    <arm_group_label>E-fied navigated rTMS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Electrical field navigated transcranial magnetic stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham E-field navigated rTMS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham electrical field navigated rTMS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-navigated rTMS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>non-navigated rTMS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental, Navigated rTMS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Navigated rTMS,</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>E-fied navigated rTMS</intervention_name>
    <description>1 hz on the superior temporal gyrus contralateral/left side with E-field navigated rTMS (Nexstim) targeted at the tonotopic representation area of the main frequency content of tinnitus</description>
    <arm_group_label>E-fied navigated rTMS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>non-navigated rTMS</intervention_name>
    <description>1 hz on the superior temporal gyrus contralateral/left side with non-navigated rTMS according to external landmarks (between T3/T4 and P3/P4 EEG-electrode locations)</description>
    <arm_group_label>non-navigated rTMS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sham E-field navigated rTMS</intervention_name>
    <arm_group_label>sham E-field navigated rTMS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Navigated rTMS</intervention_name>
    <description>1 hz on the left superior temporal gyrus with (MRI) navigated rTMS (Visor)</description>
    <arm_group_label>Experimental, Navigated rTMS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  chronic tinnitus 6 months-10 years

          -  age 18-65 years

          -  tinnitus intensity VAS at least 4/10

        Exclusion Criteria:

          -  pulsatile tinnitus

          -  objective tinnitus

          -  epilepsy, brain disease

          -  severe/recent heart disease

          -  pregnancy

          -  alcohol abuse

          -  metallic implants etc.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hanna Sahlsten</last_name>
    <email>hanna.sahlsten@hotmail.fi</email>
  </overall_contact>
  <location>
    <facility>
      <name>Turku University Hospital</name>
      <address>
        <city>Turku</city>
        <state>Varsinais-Suomi</state>
        <zip>20521</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hanna Sahlsten</last_name>
      <email>hanna.sahlsten@hotmail.fi</email>
    </contact>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 28, 2013</lastchanged_date>
  <firstreceived_date>June 24, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Tinnitus</keyword>
  <keyword>Transcranial magnetic stimulation</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Tinnitus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
